CT
GEHC icon

Clearstead Trust’s GE HealthCare GEHC Stock Holding History

Clearstead Trust’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.39K Sell
131
-192
-59% -$12.6K ﹤0.01% 662
2026
Q1 		$23K Buy
323
+192
+147% +$15.1K ﹤0.01% 416
2025
Q4 		$10.7K Sell
131
-35
-21% -$2.73K ﹤0.01% 573
2025
Q3 		$12.5K Buy
166
+39
+31% +$2.91K ﹤0.01% 543
2025
Q2 		$9.43K Buy
127
+12
+10% +$835 ﹤0.01% 607
2025
Q1 		$9.26K Sell
115
-1
-0.9% -$86 ﹤0.01% 487
2024
Q4 		$9.07K Sell
116
-42
-27% -$3.57K ﹤0.01% 363
2024
Q3 		$14.8K Hold
158
– – ﹤0.01% 331
2024
Q2 		$12.3K Sell
158
-12
-7% -$979 ﹤0.01% 347
2024
Q1 		$15.5K Buy
170
+54
+47% +$4.49K ﹤0.01% 327
2023
Q4 		$8.97K Sell
116
-41
-26% -$2.87K ﹤0.01% 342
2023
Q3 		$10.7K Hold
157
– – ﹤0.01% 336
2023
Q2 		$12.8K Buy
157
+16
+11% +$1.28K ﹤0.01% 303
2023
Q1 		$11.6K Buy
+141
New +$10.1K ﹤0.01% 294

Other funds holding GEHC

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Clearstead Trust's GEHC Position: Q2 2026 in Review

Clearstead Trust reduced its GE HealthCare (GEHC) stake by 59% in Q2 2026, selling an estimated $12.6K and leaving 131 shares worth $8.39K. The position accounts for ﹤0.01% of the portfolio, ranked #662.

Clearstead Trust first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $23K in Q1 2026. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Clearstead Trust held 131 shares of GE HealthCare worth $8.39K as of Q2 2026.
  • Clearstead Trust sold 192 GE HealthCare shares in Q2 2026, an estimated $12.6K.
  • GE HealthCare made up ﹤0.01% of Clearstead Trust's portfolio in Q2 2026, its #662 holding.
  • Clearstead Trust first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Clearstead Trust's GE HealthCare position peaked at $23K in Q1 2026.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.